Neuronetics, Inc. (FRA:NRC)

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Treatment Sessions	51.65M
Treatment Sessions Growth	13.69%
NeuroStar Advanced Therapy System	17.09M
NeuroStar Advanced Therapy System Growth	-1.71%
Other	2.61M
Other Growth	9.21%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
International	2.01M
International Growth	11.78%
United States	69.34M
United States Growth	9.35%
International	2.01M
International Growth	11.78%